Breaking News
February 21, 2018 - Early childhood immune signature predicts risk of developing asthma later on
February 21, 2018 - Stanford researchers explore how gut bacteria respond to common changes in habitat
February 21, 2018 - Household Products May Pollute the Air as Much as Your Car Does: Study
February 21, 2018 - Combo Bests Targeted Agent in mRCC
February 21, 2018 - Researchers discover brain pathway that dissociates opioid addiction from analgesia
February 21, 2018 - Scientists uncover how newly discovered gene helps grow blood vessels
February 21, 2018 - Brain’s quality control process holds clues to obesity’s roots
February 21, 2018 - Researchers to study whether menstrual cups can help prevent vaginal infections
February 21, 2018 - MS patients who feel stigmatized more likely to suffer from depression
February 21, 2018 - Vitamin D supplementation during pregnancy could protect against childhood obesity
February 21, 2018 - Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials
February 21, 2018 - Love and fear are visible across the brain instead of being restricted to any brain region
February 21, 2018 - Adults with congenital heart disease have increased risk for dementia, study finds
February 21, 2018 - Clinical trial studying type 1 diabetes reaches full enrollment
February 21, 2018 - Father’s stress affects the brain development of offspring, mice study shows
February 21, 2018 - ESRD Death Declines in Vasculitis Patients
February 21, 2018 - Taking ibuprofen for long periods found to alter human testicular physiology
February 21, 2018 - Google AI device could predict a person’s risk of a heart attack
February 20, 2018 - FDA Approves Domestic Source for Tc-99m Isotopes
February 20, 2018 - Sanofi rejects refund demand faces Philippine suit over dengue vaccine (Update)
February 20, 2018 - Researchers discover that activation of specific enzyme may help suppress tumor metastasis
February 20, 2018 - Blood or marrow transplantation survivors have higher risk of cognitive impairment
February 20, 2018 - Booze Beats Pot at Being Unhealthy: Oregon Poll
February 20, 2018 - Morning Break: ’20 Years Late’; Drugs in the Dirt; Catching Flu in the Dorm
February 20, 2018 - Another piece to the puzzle in naked mole rats’ long, cancer-free life
February 20, 2018 - Scientists identify four viruses that can produce insulin-like hormones
February 20, 2018 - New e-Health solution developed to prevent cardiovascular disease, dementia in senior citizens
February 20, 2018 - New genetic risk score could help guide screening decisions for prostate cancer
February 20, 2018 - Study finds higher risk of stroke among blacks with atrial fibrillation than whites
February 20, 2018 - Physical activity could be used as strategy for diabetes prevention
February 20, 2018 - Researchers develop sensing method for early detection of cancer and diabetes
February 20, 2018 - New wearable electronics could be game-changer for stroke rehabilitation
February 20, 2018 - Immune history influences person’s response to flu vaccine
February 20, 2018 - Research findings could help develop new drugs to prevent, treat dry eye disease
February 20, 2018 - Serenity Now! Learn to Have Patience with Patients
February 20, 2018 - Computer simulation addresses the problem of blood clotting
February 20, 2018 - Women with type 1 diabetes not protected against coronary artery disease
February 20, 2018 - Persistent bloating can be a sign of ovarian cancer, warns charity
February 20, 2018 - Trump administration proposes rule to loosen curbs on short-term health plans
February 20, 2018 - Key protein involved in epigenetic regulation of gene expression guides skin cell renewal
February 20, 2018 - Heart attack symptoms often missed in women
February 20, 2018 - Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms
February 20, 2018 - Study reveals functional dynamics of ion channels
February 20, 2018 - Study explores link between mortality risk and combustible tobacco use
February 20, 2018 - ‘She Trusted Me, and I’d Turned Her Away’
February 20, 2018 - AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies
February 20, 2018 - Fast food makes the immune system more aggressive in the long term
February 20, 2018 - Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s
February 20, 2018 - Overcoming Negative Reviews | Medpage Today
February 20, 2018 - MyD88—villain of allergies and asthma
February 20, 2018 - Food scientists develop rapid screening technique to detect pesticide residue in vegetables
February 20, 2018 - Lab-grown cerebellar cells may help explain how ASD develops at molecular level
February 20, 2018 - Scientists explore connection between bad sleep habits and stiff blood vessels
February 20, 2018 - New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy
February 20, 2018 - Do You Really Need My Signature on That?
February 20, 2018 - HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection
February 20, 2018 - Diabetes does not increase work-loss years due to early retirement
February 20, 2018 - Researchers aim to find out how PTSD affects decisions of police
February 20, 2018 - UH Cleveland Medical Center explores novel treatments for uterine fibroids
February 20, 2018 - Flu Vax Efficacy 25% Against Predominant H3N2 Strain So Far
February 20, 2018 - HIV screening most optimal at 25 years of age if no risk factors
February 20, 2018 - Loyola Medicine primary care physician offers advice to minimize risk of flu
February 20, 2018 - Safe sleep recommendations for parents that may help reduce child’s risk of SUID
February 20, 2018 - Why Do So Few Docs Have Buprenorphine Waivers?
February 20, 2018 - Low levels of alcohol good for the brain
February 20, 2018 - Experimental treatment improves invisible symptoms of a man with spinal cord injury
February 20, 2018 - Myriad’s EndoPredict offers better prediction of breast cancer recurrence, analysis shows
February 20, 2018 - Researchers identify fifteen genes that determine our facial features
February 20, 2018 - Morning Break: New Health IT Player; Luxturna No Bargain; Nuclear Freakout
February 20, 2018 - How does it compare? Hospice care at home, at assisted living facility, at nursing home
February 19, 2018 - Scientists develop water-soluble warped nanographene for bioimaging
February 19, 2018 - It’s Not Your Imagination: You’re Hungrier After Losing Weight
February 19, 2018 - Antihypertensive Use At Delivery Rising in Preeclampsia
February 19, 2018 - A centuries-old math equation used to solve a modern-day genetics challenge
February 19, 2018 - Liquid biopsies could be used as new predictive marker for metastatic TNBC
February 19, 2018 - Russian researchers develop new multi-layered biodegradable scaffolds
February 19, 2018 - Are ‘Vaccine Skeptics’ Responsible for Flu Deaths?
February 19, 2018 - Hidden genetic effects behind immune diseases may be missed, study suggests
February 19, 2018 - Emergency nurses experience regular verbal and physical abuse
February 19, 2018 - Study sheds light on biology that guides behavior across different stages of life
Cell-Free DNA May Help Pinpoint Breast Ca Survival

Cell-Free DNA May Help Pinpoint Breast Ca Survival

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study suggests that a high tumor fraction of cell-free DNA is prognostic of worse survival in patients with metastatic triple-negative breast cancer.
  • Be aware that this disease carries a poor prognosis overall, making further risk stratification an important step towards targeting potentially toxic therapies.

The tumor fraction of cell-free DNA (cfDNA) sample can be used to predict survival in patients with metastatic triple-negative breast cancer (TNBC), investigators reported.

This suggests that determining cfDNA tumor fraction via a minimally invasive blood test can provide “important prognostic information beyond standard clinicopathologic factors,” according to Daniel G. Stover, MD, of the Ohio State University Comprehensive Cancer Center in Columbus, and colleagues.

A diagnosis of TNBC means that the breast cancer cells have tested negative for hormone epidermal growth factor receptor 2 (HER-2), and estrogen and progesterone receptors. TNBC accounts for 10% to 15% of breast cancers, yet is responsible for more than one-third of breast cancer deaths, the authors wrote in the Journal of Clinical Oncology.

They also noted that TNBC is characterized by relatively few mutations, but widespread somatic copy number alterations (SCNAs), suggesting SCNAs play a critical from in the formation of TNBC tumors. Stover’s group evaluated SCNAs in metastatic TNBC via cfDNA to determine whether cfDNA tumor fraction was associated with overall metastatic TNBC survival.

For this retrospective cohort study, they identified 506 plasma samples from 164 patients with biopsy-proven metastatic TNBC. All patients received chemotherapy before blood collection, with most patients receiving neoadjuvant or adjuvant anthracycline and taxane-based chemotherapy.

The researchers used an algorithm, ichorCNA, to profile SCNAs and quantify tumor fraction (TFx) in cfDNA from low-coverage whole-genome sequencing without prior knowledge of the genomic changes in the patient’s tumor.

Stover’s group was able to determine tumor fraction of cfDNA for 158 patients (96.3%). Also, 101 of those 158 patients (63.9%) had at least one sample with TFx equal to or greater than the prespecified cfDNA tumor fraction threshold of 10%.

Crucially, they found that patients with the higher tumor fraction of ≥10% was associated with a “significantly shorter survival” — median 6.4 months versus 15.9 months — and that this association remained significant independent of clinicopathologic factors (hazard ratio 2.14, 95% CI 1.4-3.8).

The analysis also identified several genes — NOTCH2, AKT2, and AKT3 — that had copy number gains enriched in metastatic TNBCs relative to primary TNBCs. In an accompanying commentary, Sarah-Jane Dawson, MD, PhD, of the Peter MacCallum Cancer Center in Melbourne, Australia, and colleague observed that this “sheds light on important genes and signaling pathways that may be perturbed in metastatic disease.”

Stover’s group also found that more than half of metastatic TNBCs harbored gains or amplification of 18q11, 19p13, or both, which was significantly more frequent than in primary TNBCs. “Gain or amplification of both regions identifies a subset of TNBC rapid progressors with remarkably poor survival in the metastatic, and also the primary setting,” they wrote.

The study illustrates a “framework for minimally invasive genomic characterization of metastatic cancer and subsequent integration with clinicopathologic data and patient outcomes,” the authors noted. “This approach has the potential to reveal clinically useful biomarkers while identifying unique genomic features of metastatic cancer and may advance our understanding of metastasis, drug resistance, and novel therapeutic targets.”

Dawson’s group wrote that with “the current lack of prognostic markers in metastatic TNBC, a reliable marker that can be obtained using a minimally invasive blood draw could have important implications.”

They also pointed out that it was important to note that the SCNA analysis was only performed on those patients (63.9% of the cohort) whose TFx was ≥10%. “High-confidence copy number calls could not be achieved for samples with a TFx < 10%, " they wrote, adding this would "limit the applicability of this approach in patients with early-stage disease."

But considering the challenges posed by the heterogeneity of TNBC, and the lack of targeted therapeutic options in treating the disease, the “era of comprehensive molecular characterization promises to pave the way forward,” Dawson’s group wrote.

The study was supported by the Gerstner Family Foundation, Susan G. Komen for the Cure, The Pink Agenda, Breast Cancer Research Foundation, the V Foundation for Cancer Research, and Dana-Farber/Harvard Cancer Center National Cancer Institute Specialized Programs of Research Excellence in Breast Cancer.

Stover disclosed no relevant relationships with industry. Co-authors disclosed multiple relevant relationships with industry.

Dawson and co-author disclosed support from Cancer Therapeutics CRC, the National Breast Cancer Foundation, the Victorian Cancer Agency, and the National Health and Medical Research Council of Australia.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-12-01T00:00:00-0500

last updated

Tagged with:

About author

Related Articles